Video yükleniyor...
Video Yüklenemedi
India’s first CAR-T cell therapy is developed through collaboration between the Indian Institute of Technology, Bombay and Tata Memorial Hospital in association with industry partner ImmunoACT. So, we have two of India’s pioneering research institutes in their respective fields, joining hands with industry for a humanitarian cause.
110,736 görüntüleme • 2 yıl önce •via X (Twitter)
9 Yorum

Yogendar Kumar Jain2 yıl önce
प्रणाम राष्ट्रपति जी 🙏 जय भारत 🇮🇳

Sunil Bahl2 yıl önce
Incredible achievement. This is huge not only for Indian patients but also for all of South Asia and some African nations whose patients come to India for treatment. 👏👏👏🌺

Rajesh Ranjan Mishra2 yıl önce
🕉️🙏 Its a really very good achievement.

Charudutta Panigrahi2 yıl önce
Tremendously encouraging

Ankit Raj Goyal2 yıl önce
@TVMohandasPai Congrats and Jai hind 🇮🇳🇮🇳

AJAY KISHORE JHA2 yıl önce
@TataMemorial @PMOIndia @aiims_newdelhi मुझे मेरी पत्नी के ओवरी कैंसर के ईलाज के लिए Tab. Rucaparib 500mg- BD एम्स दिल्ली के डॉक्टर ने लिखा है जिसका कि एक महीना दवाई का कीमत लगभग 60000 से 65000 रूपये है। पैसे के अभाव में ईलाज नहीं हो पा रहा है। कृपया मदद करें ।

जय गोंडवाना2 yıl önce
Great

Shubham2 yıl önce
#BharatIsWakingUp 🙏🌺

CHANDAN2 yıl önce
mahamahim ji, ye to sabse badhiya news hai.
